BioCarta's curated pathways are fundamentally useful for identifying key molecular targets in cancer. By mapping out how various genes and proteins interact within a cell, researchers can pinpoint critical points in these pathways that may be disrupted in cancerous cells. This allows for the development of targeted therapies aimed at these specific disruptions.
